Efficacy and Safety of Emapalumab and Anakinra in Reducing Hyperinflammation and Respiratory Distress in Patients With COVID-19 Infection.
Clinical trial NCT04324021 · TERMINATED
Trial details
- NCT number
- NCT04324021
- Sponsor
- Swedish Orphan Biovitrum
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-02
- Primary completion
- 2020-11-13
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.